2024-11-20 10:42:04
IASO Biotherapeutics' Equecabtagene Autoleucel, the World's First CAR-T for Treatment of NMOSD, Receives IND Application Acceptance by NMPA
Health/ 2023-07-22
IASO Biotherapeutics' Equecabtagene...

SAN JOSE,Calif.,NANJING,ChinaandSHANGHAI,May 28,2022-- IASO Biotherapeutics (IASO Bio),a clinical-stage biopharmaceutical company engaged in...

InxMed IN10018 at ASCO 2022 demonstrates robust efficacy in patients with platinum-resistant recurrent ovarian cancer
Health/ 2023-07-22
InxMed IN10018 at ASCO 2022 demonstrates...

NANJING,China,May 29,2022-- InxMed Co.,Ltd,a clinical-stage biotechnology company dedicates on developing innovative therapies targeting str...

CUSMail

CusMail provide the Latest News , Business and Technology News Release service. Most of our news is paid for distribution to meet global marketing needs. We can provide you with global market support.

© CUSMAIL. All Rights Reserved. Operate by Paid Release